American Psychiatric Association & American Academy of Child and Adolescent Psychiatry (2005) ParentsMedGuide. The Use of Medication in Treating Childhood and Adolescent Depression: Information for Patients and Families. http://www.ParentsMedGuide.org.
Anthony, P. (2005) FDA ‘Drug Watch’ early warnings will have lasting negative effect, PhRMA says. Pink Sheets, June 7, no. 001. 14050607001.
Beasley, C. M., Dornseif, B. E., Bosomworth, J. C.
et al (1991) Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ, 303, 685–692.
Brown, T. & Wilkinson, G. (1998) Critical Reviews in Psychiatry. London: Gaskell.
Fassler, D. (2005) FDA's Drug Approval Process: Up to the Challenge? Senate Hearing, 1 March. Washington, DC: US Senate Committee on Health, Education, Labor and Pensions.
Fergusson, D., Doucette, S., Cranley-Glass, K.
et al (2005) The association between suicide attempts and SSRIs. A systematic review of 677 randomized controlled trials representing 85,470 participants. BMJ, 330, 396–399.
Hommes, D. W., Bura, A., Mazzolai, L.
et al (1992) Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. Annals of Internal Medicine, 116, 279–284.
Khan, A., Warner, H. A. & Brown, W. A. (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. Archives of General Psychiatry, 57, 311–317.
Khan, A., Leventhal, R. M., Khan, S.
et al (2002) Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database. Journal of Affective Disorders, 68, 183–190.
Khan, A., Khan, S., Kolts, R.
et al (2003) Suicide rates in clinical trials of SSRIs, other antidepressants and placebo. Analysis of FDA reports. American Journal of Psychiatry, 160, 790–792.
Messori, A., Scrocarro, G. & Martini, N. (1993) Calculation errors in meta-analysis. Annals of Internal Medicine, 118, 77–78.
Oxman, A. D., Cook, D. J. & Guyatt, G. H. (1994) Users' guides to the medical literature. VI: How to use an overview. JAMA, 272, 1367–1371.
Poole, C. (1987) Beyond the confidence interval. American Journal of Public Health, 77, 195–199.
Stang, A., Hense, H.-W., Jockel, H.
et al (2005) Is it unethical to use a placebo in a clinical trial?
PLoS Medicine, 2, 0177–0180. DOI: 10.1371/journal.pmed.0020072.
Rothman, K. J., Lanes, S. & Robins, J. (1993) Casual inference. Epidemiology, 4, 555–556.
Teicher, M. H., Glod, C. & Cole, J. O. (1990) Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 147, 207–210.
Wheadon, D. E., Rampey, A. H., Thompson, V. L.
et al (1992) Lack of an association between fluoxetine and suicidality in bulimia nervosa. Journal of Clinical Psychiatry, 53, 235–241.